LF
MRNA icon

Lee Financial’s Moderna MRNA Stock Holding History

Lee Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,601
Closed -$309K – 187
2024
Q2 		$309K Hold
2,601
– – 0.05% 118
2024
Q1 		$277K Buy
2,601
+1
+0% +$101 0.05% 124
2023
Q4 		$259K Sell
2,600
-12
-0.5% -$1.01K 0.05% 121
2023
Q3 		$270K Hold
2,612
– – 0.05% 113
2023
Q2 		$317K Hold
2,612
– – 0.06% 109
2023
Q1 		$401K Sell
2,612
-4
-0.2% -$660 0.07% 94
2022
Q4 		$470K Hold
2,616
– – 0.08% 100
2022
Q3 		$309K Buy
2,616
+4
+0.2% +$607 0.06% 118
2022
Q2 		$373K Buy
2,612
+4
+0.2% +$572 0.07% 105
2022
Q1 		$449K Sell
2,608
-4
-0.2% -$673 0.08% 99
2021
Q4 		$663K Buy
2,612
+4
+0.2% +$1.17K 0.12% 84
2021
Q3 		$1M Hold
2,608
– – 0.21% 60
2021
Q2 		$613K Buy
2,608
+8
+0.3% +$1.43K 0.13% 83
2021
Q1 		$340K Hold
2,600
– – 0.08% 106
2020
Q4 		$272K Buy
2,600
+1,300
+100% +$132K 0.07% 110
2020
Q3 		$92K Buy
+1,300
New +$90.6K 0.03% 159

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lee Financial's MRNA Position: Q3 2024 in Review

Lee Financial sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,601 shares — an estimated $309K sold.

Lee Financial first reported a position in MRNA in Q3 2020 and held it in 16 quarters. The position peaked at $1M in Q3 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Lee Financial reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Lee Financial sold 2,601 Moderna shares in Q3 2024, an estimated $309K.
  • Lee Financial first reported a position in Moderna in Q3 2020 and held it in 16 quarters.
  • Lee Financial's Moderna position peaked at $1M in Q3 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Lee Financial's 13F filing for Q3 2024, filed 14 Nov 2024.